Journal Menu
► ▼ Journal Menu-
- Current Oncology Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Editorial Office
- 30th Anniversary
Journal Browser
► ▼ Journal Browser-
arrow_forward_ios
Forthcoming issue
arrow_forward_ios Current issue - Volumes not published by MDPI
Need Help?
Announcements
23 September 2022
Recruiting Section Editors-in-Chief for Current Oncology
Current Oncology (ISSN: 1718-7729) is an international, peer-reviewed, open access journal on clinical oncology. It is published monthly online by MDPI.
To develop different research areas and continue to attract high-quality papers, Current Oncology is recruiting Section Editors-in-Chief (https://www.mdpi.com/journal/curroncol/sections) for the following Sections:
- “Gastrointestinal Oncology”;
- “Genitourinary Oncology”;
- “Palliative and Supportive Care”;
- “Dermato-Oncology”.
If you are an active researcher in one of the fields and are passionate about publishing cutting-edge research, please do not hesitate to contact us at [email protected]. More information can be found on our homepage: https://www.mdpi.com/journal/curroncol.
Responsibilities of the Section Editor-in-Chief include the following:
- Deciding whether a manuscript should be accepted based on the reports we collect;
- Reviewing a small number of papers per year and managing the Section in collaboration with other editors;
- Promoting Current Oncology and increasing its visibility at academic conferences.
As a Section Editor-in-Chief, you have the opportunity to publish one paper per year free of charge in our journal. The term for this position is two years and can be renewed.
By combining our rigorous editorial policies with your expertise, we can maintain a high-quality journal. Thank you in advance for your interest. We look forward to collaborating with you soon.
Current Oncology Editorial Office